We pay a lot of attention to enrollment of diverse populations in clinical trials – Estelamari Rodriguez
Sylvester Comprehensive Cancer Center posted on LinkedIn:
“Dr. Estelamari Rodriguez, thoracic oncologist and researcher is devoted to outreach, communication and connecting with patients. We recently chatted to find out more about her work and her approach to lung cancer care.
Tell us a little bit about Sylvester’s semphasis on ensurig a diverse patient base in its clinical trials.
We pay a lot of attention to enrollment of diverse populations in clinical trials. I’m particularly proud of the work that our experimental therapeutics clinic has done to increase access to innovative, early-phase clinical trials for underserved communities.
I am also proud of the next generation of residents and fellows that we have mentored over the years to work in cancer equity and disparities research. I am proud of the fact that about 50% of our enrollees in our clinical trials are Hispanics and that we are engaging with the Caribbean and Black Afro-Caribbean communities that are also included in our trials.
This World Lung Cancer Day learn more about Dr. Estelamari Rodriguez.”